PortfoliosLab logo

Apellis Pharmaceuticals, Inc. (APLS)

Equity · Currency in USD · Last updated Jan 24, 2023

Company Info

ISINUS03753U1060
CUSIP03753U106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$50.61
Year Range$35.07 - $68.67
EMA (50)$51.43
EMA (200)$50.82
Average Volume$1.21M
Market Capitalization$5.60B

APLSShare Price Chart


Loading data...

APLSPerformance

The chart shows the growth of $10,000 invested in Apellis Pharmaceuticals, Inc. in Nov 2017 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $36,073 for a total return of roughly 260.73%. All prices are adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2023
-11.83%
-0.10%
APLS (Apellis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

APLSCompare to other instruments

Search for stocks, ETFs, and funds to compare with APLS

Apellis Pharmaceuticals, Inc.

APLSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD-2.13%4.70%
1M-0.49%4.55%
6M-4.13%1.47%
1Y42.72%-8.60%
5Y23.10%7.21%
10Y28.06%8.89%

APLSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-14.83%5.61%19.47%-14.33%-4.78%9.10%24.46%7.52%12.87%-11.43%-17.46%3.56%
2021-22.60%8.81%-10.92%18.08%11.07%12.30%1.25%2.91%-49.95%-6.74%36.89%12.36%
202034.26%-15.79%-22.62%27.92%-1.69%-3.06%-20.73%19.08%-2.14%5.73%47.77%21.34%
20196.14%8.21%28.71%1.59%1.41%26.13%10.22%4.19%-17.22%22.00%-8.54%13.91%
2018-23.50%10.42%20.62%9.05%-15.35%7.79%-16.36%5.22%-8.16%-21.32%9.65%-14.02%
2017-1.50%57.02%

APLSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Apellis Pharmaceuticals, Inc. Sharpe ratio is 0.52. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.001.50AugustSeptemberOctoberNovemberDecember2023
0.52
-0.43
APLS (Apellis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

APLSDividend History


Apellis Pharmaceuticals, Inc. doesn't pay dividends

APLSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember2023
-27.53%
-16.19%
APLS (Apellis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

APLSWorst Drawdowns

The table below shows the maximum drawdowns of the Apellis Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Apellis Pharmaceuticals, Inc. is 61.77%, recorded on Oct 24, 2018. It took 216 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-61.77%Apr 17, 2018134Oct 24, 2018216Sep 5, 2019350
-59.6%Feb 11, 202025Mar 17, 2020174Nov 20, 2020199
-55.99%Jul 6, 202183Oct 29, 2021
-43.83%Jan 5, 201825Feb 9, 201822Mar 14, 201847
-31.32%Sep 9, 201917Oct 1, 201967Jan 7, 202084
-28.91%Jan 11, 202151Mar 24, 202147Jun 1, 202198
-21.52%Mar 19, 201810Apr 2, 20187Apr 11, 201817
-12.47%Dec 12, 20172Dec 13, 20176Dec 21, 20178
-8.38%Dec 9, 20203Dec 11, 20202Dec 15, 20205
-8.03%Jun 15, 20212Jun 16, 202111Jul 1, 202113

APLSVolatility Chart

Current Apellis Pharmaceuticals, Inc. volatility is 38.96%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%AugustSeptemberOctoberNovemberDecember2023
38.96%
17.05%
APLS (Apellis Pharmaceuticals, Inc.)
Benchmark (^GSPC)